SONIRE Therapeutics
Surgical Instruments & Devices
Overview
SONIRE Therapeutics develops a next-generation ultrasound-guided high-intensity focused ultrasound (HIFU) therapy system leveraging technology and know-how originating from Tokyo Women's Medical University, Tohoku University, and Tokyo Medical University. The company designs non-invasive, radiation-free HIFU solutions intended to treat intractable cancers such as pancreatic cancer. SONIRE targets clinical and hospital markets to provide alternative therapeutic options for patients and clinicians dealing with difficult-to-treat malignancies.
Funding and backers
Total raised
$18M
1 round on record
Latest round
$18M
Series A · Apr 2026 · 6 mo ago
Team
51-200
employees, estimated range
Backers
1
Daiwa Corporate Investment
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
2 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 15
Raised a round Series A $18M · led by Santé Ventures · YahooFinance
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Apr 2026 | $18M | Santé Ventures lead, Fast Track Initiative | YahooFinance |
Backed byfrom the funds' portfolios and accelerator catalogs
Financials
Total raised
$18M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2026 | $18M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Daiwa Corporate InvestmentVia a fund
149 portfolio companies: Daiwa PI Partners, Daiwa Energy & Infrastructure Co. Ltd., CREWT and 146 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Sonire Therapeutics Awarded $13 Million Through NEDO Deep-Tech Startups Support Program (DTSU) to Advance Global Commercialization of Pancreatic Cancer Treatment
Read more
Report
Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development
Sonire Therapeutics, a U.S. based clinical-stage medical device company, today announced $18M in Series A financing. The round was led by Santé Ventures with participation from Fast Track Initiative (FTI), Nomura SPARX Investment (Japan Growth Capital Inv
Read more
Report